Michael Worwood

Michael Worwood has a background in various roles within the pharmaceutical and healthcare industry. Most recently, they worked as a Research Associate at Quell Therapeutics, starting in January 2023. Prior to that, they served as a Research Associate - GCLP at Gyroscope Therapeutics from January 2022 to December 2022. Michael also worked as a GCP Compliance Officer at The Institute of Cancer Research from June 2021 to January 2022. Before that, they held the position of Global Regulatory Specialist at RB from November 2020 to June 2021.

From 2016 to 2020, Michael Worwood attended the Royal Veterinary College, University of London, where they pursued a Bachelor of Science (BSc) and Master of Science (MSci) degree in Biology/Biological Sciences, with a focus on general studies in the field.